Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SURGE: Rilonacept for Acute Gout Flare
NCT00855920Phase 3Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Mar 2009
- Primary completion
- Feb 2010
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of rilonacept in gout, sponsored by Regeneron Pharmaceuticals. Started Mar 2009; status: completed.
02
Drugs
rilonacept
03
Conditions
gout
Beyond the preview
Go deeper on NCT00855920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00855920.